Argenx
ARGX
#438
Rank
$57.10 B
Marketcap
$913.68
Share price
4.10%
Change (1 day)
68.96%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of December 2025 : $47.16 Million USD

According to Argenx 's latest financial reports the company's total debt is $47.16 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2017 to 2020)

Total debt by year

Year Total debt Change
2024-12-31$39.05 M95.27%
2023-12-31$20 M60.95%
2022-12-31$12.42 M8.38%
2021-12-31$11.46 M18.72%
2020-12-31$9.65 M31.94%
2019-12-31$7.31 M
2018-12-31N/A
2017-12-31N/A
2013-12-31N/A-100%
2012-12-31$2.95 M3.93%
2011-12-31$2.84 M